# Emerald Innovations, Inc.

Canonical: https://abierto.us/vendors/emerald-innovations-inc-mde4d4w9j7h3

- UEI: MDE4D4W9J7H3
- CAGE: 8AVC5
- Location: Cambridge, MA
- Awards in window: 1 (3 transactions), $0 obligated, June 13, 2025 to May 19, 2026

## Awarding agencies

- Food and Drug Administration: 1 awards, $0

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $0

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75F40124C00013 (definitive contract): $0, FDA Office of Acq Grant SVCS. The Purpose of This Modification Is to Change the Contracting Officer'S Representative (Cor) from Mark Lauda to Darby Kozak.. https://www.usaspending.gov/award/CONT_AWD_75F40124C00013_7524_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/emerald-innovations-inc-mde4d4w9j7h3.